Neurohumoral activation in heart failure

AA Manolis, TA Manolis, AS Manolis - International Journal of Molecular …, 2023 - mdpi.com
In patients with heart failure (HF), the neuroendocrine systems of the sympathetic nervous
system (SNS), the renin–angiotensin–aldosterone system (RAAS) and the arginine …

Sudden death in heart failure with preserved ejection fraction and beyond: an elusive target

AS Manolis, AA Manolis, TA Manolis, H Melita - Heart Failure Reviews, 2019 - Springer
Heart failure (HF) with preserved ejection fraction (HFpEF) represents half of HF patients,
who are more likely older, women, and hypertensive. Mortality rates in HFpEF are higher …

[PDF][PDF] PIONEERing the in-hospital initiation of sacubitril-valsartan

J Jarcho - N Engl J Med, 2019 - jvsmedicscorner.com
In 2015, sacubitril–valsartan was approved in Europe and the United States as a new
therapeutic agent for heart failure with reduced ejection fraction. Approval was based …

The Controversy of Renin–Angiotensin-System Blocker Facilitation Versus Countering COVID-19 Infection

AS Manolis, TA Manolis, AA Manolis… - Journal of …, 2020 - journals.lww.com
The ongoing COVID-19 pandemic has produced serious turmoil world-wide. Lung injury
causing acute respiratory distress syndrome seems to be a most dreaded complication …

Ventricular Arrhythmias in Heart Failure

AS Manolis, AA Manolis, TA Manolis - Heart Failure, 2022 - taylorfrancis.com
Ventricular arrhythmias responsible for sudden cardiac death (SCD) have a considerable
share in heart failure (HF) mortality and may be related to myocardial ischemia, scar, or …

Hybrid heart failure treatment

AS Manolis, AA Manolis - Rhythmos, 2021 - rhythmos.gr
A case of refractory heart failure (HF) is presented in a 64-year-old gentleman with ischemic
cardiomyopathy and severe left ventricular dysfunction, who availed himself of currently …

[引用][C] End-tidal karbondioksit düzeyi ile kalp yetmezliği sınıflaması arasındaki ilişkinin değerlendirilmesi

M Tepe - Tıp Fakültesi